Amanote Research
Register
Sign In
Real-World Evidence of Iron Chelation Therapy in Transfusion-Dependent MDS Patients: A Portuguese Hospital Registry
Value in Health
- United Kingdom
doi 10.1016/j.jval.2015.09.2390
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2015
Authors
S Rodrigues
A Almeida
D Viriato
M Antunes
Publisher
Elsevier BV
Related search
Successful Chelation Therapy in a Case of Neonatal Iron Overload Following Intravascular Intrauterine Transfusion
Journal of Perinatology
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study
Annals of Hematology
Medicine
Hematology
Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
In Search of the Optimal Iron Chelation Therapy for Patients With Thalassemia Major
Haematologica
Hematology
Daily Alternating Deferasirox and Deferiprone Therapy Successfully Controls Iron Accumulation in Untreatable Transfusion Dependent Thalassemia Patients
American Journal of Hematology
Hematology
Iron Overload in Non-Transfusion-Dependent Thalassemia
Thalassemia Reports
Treatment Registry for Outcomes in Patients With Castration-Resistant Prostate Cancer (TRUMPET): A Methodology for Real-World Evidence and Research
Future Oncology
Medicine
Cancer Research
Oncology
Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry
Cancers
Cancer Research
Oncology
Iron Chelation Therapy in Myelodysplastic Syndromes: Where Do We Stand?
Expert Review of Hematology
Hematology
